Business
Press Release Dec 09 2022
Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 09-Dec-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Desonide Cream, 0.05%.
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 09-Dec-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Desonide Cream, 0.05%. View Attachment","length":354,"tagName":"div"}]